Small molecule inhibitors of FZD7 Receptor (Frizzled 7) for treatment of triple negative breast cancer

Schrift Standard Fett
Login

Forschungsstelle

INNOSUISSE

Projektnummer

17239.1;4 PFLS-LS

Projekttitel

Small molecule inhibitors of FZD7 Receptor (Frizzled 7) for treatment of triple negative breast cancer

Projekttitel Englisch

Small molecule inhibitors of FZD7 Receptor (Frizzled 7) for treatment of triple negative breast cancer: MIP: AIDD

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung	-	-	-
Abstract	-	-	-

Erfasste Texte

Kategorie	Text
Kurzbeschreibung (Englisch)	Small molecule inhibitors of FZD7 Receptor (Frizzled 7) for treatment of triple negative breast cancer
Abstract (Englisch)	This project represents an approach towards a first-in-class treatment of Triple Negative Breast Cancer (TNBC). AIDD together with UNIL and UNIGE will target small molecule inhibitors of the FZD7 receptor, a novel target for the treatment of TNBC. Assay development and high throughput screening followed by a small molecule optimization process will generate a proof of concept data package capable of attracting partners from the pharmaceutical industry.

Kategorie

Text

Kurzbeschreibung
(Englisch)

Small molecule inhibitors of FZD7 Receptor (Frizzled 7) for treatment of triple negative breast cancer

Abstract
(Englisch)

This project represents an approach towards a first-in-class treatment of Triple Negative Breast Cancer (TNBC). AIDD together with UNIL and UNIGE will target small molecule inhibitors of the FZD7 receptor, a novel target for the treatment of TNBC. Assay development and high throughput screening followed by a small molecule optimization process will generate a proof of concept data package capable of attracting partners from the pharmaceutical industry.